Katherine Bridge, PhD

Principal Investigator // Blood Cancer Researcher // Cell Biologist // Innovator // @young_EHA @ISEHsociety committees // Mum of 3 // Bring coffee

[Katherine Bridge, PhD @BridgeKatherine]

Equal parenting.
Enabling mothers everywhere to be great at other stuff too.
Granted, 3-4 women will tell @bridge_luke he's #suchagooddad (with 3 kids, on his own??) BUT men who take equal childcare responsibility CHANGE the WORLD, one #workingmom #academicmom at a time 🌍❤️💪🏻

[Katherine Bridge, PhD @BridgeKatherine]

Any #academics in my network working in or near the field of #CART therapy? Asking for an industry friend organising a conference, looking for speakers. UK or Europe based preferable.

[Katherine Bridge, PhD @BridgeKatherine]

Announcing the launch of the @EHA_Hematology Mentorship Program - call for Mentors now open. Apply today!

[Centre for Blood Research @CBR_UoY]

#NewPaper "PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia" @Nature

https://t.co/0heTb0wbbM

[Katherine Bridge, PhD @BridgeKatherine]

It was a pleasure to host you @bloodcancer_uk today @CBR_UoY. Thank you for all you do for people with blood cancer, for your insightful questions, enthusiasm and a humbling, humanising refresh on why we do what we do. @hitchcock_lab @AdeleKFielding #bloodcancer #research

[Ashley Day @ashleyday1]

Trustees at @bloodcancer_uk got a brilliant tour of the Centre for Blood Research at @UniOfYork with Prof Ian Hitchcock, @BridgeKatherine and the team today. Great to see funding translated into science!

[Ashley Day @ashleyday1]

Trustees at @bloodcancer_uk got a brilliant tour of the Centre for Blood Research at @UniOfYork with Prof Ian Hitchcock, @BridgeKatherine and the team today. Great to see funding translated into science!

[Nature Communications @NatureComms]

A link between the activity of a lineage-specific transcription factor PU.1 and epigenetic modulators mediating the response to glucocorticoids in acute lymphoblastic leukemia @charles_debock @KidsCancerInst @BridgeKatherine @AndrewHolding @UniOfYork @UNSW
https://t.co/TMZX9tWnD3

[Katherine Bridge, PhD @BridgeKatherine]

Congratulations @charles_debock and team!

[Charles de Bock @charles_debock]

Following our publication on T-ALL this week, pleased to share another paper from our group now published in @NatureComms linking PU.1 to glucocorticoid sensitivity in B-ALL https://t.co/IC9bwbFo0k which was a massive team effort @KidsCancerInst ; 🧵n/8 below

[Katherine Bridge, PhD @BridgeKatherine]

@charles_debock @NatureComms @KidsCancerInst So great to see this work out, definitely a few happenstance conversations at @ISEHSociety meetings went into the mix here! Congratulations all.

[Katherine Bridge, PhD @BridgeKatherine]

Registration for the ISEH Ask the PIs event is open for trainees! Attend this networking event to connect with me and other PIs on career advancement and insight to navigating your path to independence. https://t.co/p24P7SQXLs…
@ISEHSociety

[York Biomedical Research Institute @YBRI_UoY]

Fully funded PhD opportunity @DiMeN_DTP @JNB_lab @BridgeKatherine @mjplevin @Labcorp @CBR_UoY

Enhancing LNP-RNA delivery to leukemia cells through cutting-edge cryogenic electron tomography (cryo-ET) #DiMeN #CancerResearch

Deadline: 13/12/24

https://t.co/9EgkZfgNfs

[Katherine Bridge, PhD @BridgeKatherine]

My feed here now mostly drowns out the posts I actually care about with randomness, so I'm migrating over to LinkedIn. My profile is below, connect with me and I'll see you on the other side!

https://t.co/Fsg8K64rQj

[Katherine Bridge, PhD @BridgeKatherine]

@tyson_sharp Thanks Tyson!

[Katherine Bridge, PhD @BridgeKatherine]

Delighted to share the first study from my group:
"HIF-1 activated by PIM1 assembles a pathological transcription complex and regulon that drives JAK2V617F MPN disease", now under review.
https://t.co/oEL52SjSYI

[Katherine Bridge, PhD @BridgeKatherine]

@SamuelJohnTayl1 Congratulations Sam and team! Great to see this (re)directive (see what I did there) work on manipulating TFs in haematopoiesis hitting the stage.

[Katherine Bridge, PhD @BridgeKatherine]

See you back here in a year or so after revisions😅😅😅😅😅

[Katherine Bridge, PhD @BridgeKatherine]

And finally, thank you to the most important and all-twitterless stars working with me David Kealy, Ruth Ellerington, Cathy Hawley, Gillian Caalim, Jakub Lukaszonek, Nicole-Mae Blacknell and Bryce Drylie.